Impact of grazoprevir and elbasvir in the treatment of hepatitis C virus–infected patients with chronic kidney disease and end‐stage renal disease
Fernando Pedraza, Marco Ladino, David Roth – 27 May 2016
Circulating let‐7 levels in plasma and extracellular vesicles correlate with hepatic fibrosis progression in chronic hepatitis C
Kentaro Matsuura, Valeria De Giorgi, Cathy Schechterly, Richard Y. Wang, Patrizia Farci, Yasuhito Tanaka, Harvey J. Alter – 26 May 2016 – The goal of this study was to determine whether an association exists between circulating microRNA (miRNA) levels and disease progression in chronic hepatitis C (CHC), whether plasma or extracellular vesicles (EVs) were optimal for miRNA measurement and their correlation with hepatic miRNA expression, and the mechanistic plausibility of this association. We studied 130 CHC patients prospectively followed over several decades.
Editorial Board
26 May 2016
ISSN
26 May 2016
The lymphatic system: A new frontier in hepatology
Yasuko Iwakiri – 26 May 2016
Reply
Shao‐Lai Zhou, Jian Zhou – 26 May 2016
Severe drug‐induced liver injury related to therapy with dimethyl fumarate
Christoph Jüngst, Yoo‐Jin Kim, Frank Lammert – 26 May 2016
Combined hepatocellular‐cholangiocarcinoma in a patient with Abernethy malformation and tetralogy of Fallot: A case report
Sofie Happaerts, Amélie Foucault, Jean Sébastien Billiard, Bich Nguyen, Franck Vandenbroucke‐Menu – 26 May 2016 – Abernethy malformation is a rare congenital anomaly of the portal vein where the portal blood bypasses the liver. We report the first case of a patient with Abernethy malformation and tetralogy of Fallot associated with nodular regenerative hyperplasia and focal nodular hyperplasia (FNH), which finally evolved to a giant hepatocellular‐cholangiocarcinoma (HCC‐CC) of the liver, successfully resected. (Hepatology 2016;64:1800‐1802)
Circulating let‐7 levels in plasma and extracellular vesicles correlate with hepatic fibrosis progression in chronic hepatitis C
Kentaro Matsuura, Valeria De Giorgi, Cathy Schechterly, Richard Y. Wang, Patrizia Farci, Yasuhito Tanaka, Harvey J. Alter – 26 May 2016 – The goal of this study was to determine whether an association exists between circulating microRNA (miRNA) levels and disease progression in chronic hepatitis C (CHC), whether plasma or extracellular vesicles (EVs) were optimal for miRNA measurement and their correlation with hepatic miRNA expression, and the mechanistic plausibility of this association. We studied 130 CHC patients prospectively followed over several decades.